Literature DB >> 20822941

Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain.

Anne Kari Knudsen1, Cinzia Brunelli, Stein Kaasa, Giovanni Apolone, Oscar Corli, Mauro Montanari, Robin Fainsinger, Nina Aass, Peter Fayers, Augusto Caraceni, Pål Klepstad.   

Abstract

BACKGROUND: This study is part of a research program to reach consensus on an international cancer pain classification system. A confirmative and explorative approach was applied to investigate which of the variables identified in the literature, by experts and patients that are associated with pain.
METHODS: Data from an international, multicentre, cross-sectional study of cancer patients treated with opioids were investigated. Dependent variables were: average pain, worst pain, and pain relief (11-point Numerical Rating Scales). Forty-six independent variables were chosen based upon previous studies. Bivariate analyses identified independent variables associated with at least one of the dependent ones; 21 were included in multivariate linear regression analyses.
RESULTS: Two thousand two hundred and seventy-eight patients were investigated; 52% males, mean age 62 years, mean Karnofsky Performance Status 59%, mean daily opioid oral equivalent dose 341 mg. Fifty-eight percent had breakthrough pain. Mean pain scores were: average pain 3.5, worst pain 5.3 and pain relief 74%. Variables most strongly associated with these three dependent variables were: breakthrough pain, psychological distress, sleep, and opioid dose.
CONCLUSIONS: Breakthrough pain and psychological distress were confirmed as key variables of a future classification system. Candidate variables were: sleep, opioid dose, pain mechanism, use of non-opioids, pain localisation, cancer diagnosis, location of metastases, and addiction.
Copyright © 2010 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20822941     DOI: 10.1016/j.ejpain.2010.08.001

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  20 in total

1.  Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain during participation in a psychoeducational intervention study to improve pain management.

Authors:  Dale J Langford; Steven M Paul; Debu Tripathy; Claudia West; Marylin J Dodd; Karen Schumacher; Christine Miaskowski
Journal:  J Pain       Date:  2011-03-22       Impact factor: 5.820

Review 2.  Managing difficult pain conditions in the cancer patient.

Authors:  Sebastiano Mercadante
Journal:  Curr Pain Headache Rep       Date:  2014-02

3.  Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses.

Authors:  Ragnhild Habberstad; M J Hjermstad; C Brunelli; S Kaasa; M I Bennett; K Pardon; P Klepstad
Journal:  Support Care Cancer       Date:  2018-08-13       Impact factor: 3.603

4.  Reply to "the pain, the oncologist".

Authors:  Sunil Xavier Raj; Stein Kaasa
Journal:  Support Care Cancer       Date:  2014-10-08       Impact factor: 3.603

5.  Clinical and genetic factors related to cancer-induced bone pain and bone pain relief.

Authors:  Emanuela Scarpi; Daniele Calistri; Pål Klepstad; Stein Kaasa; Frank Skorpen; Ragnhild Habberstad; Oriana Nanni; Dino Amadori; Marco Maltoni
Journal:  Oncologist       Date:  2014-10-23

Review 6.  Differences between opioids: pharmacological, experimental, clinical and economical perspectives.

Authors:  Asbjørn M Drewes; Rasmus D Jensen; Lecia M Nielsen; Joanne Droney; Lona L Christrup; Lars Arendt-Nielsen; Julia Riley; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

7.  Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery.

Authors:  Birha McCann; Christine Miaskowski; Theresa Koetters; Christina Baggott; Claudia West; Jon D Levine; Charles Elboim; Gary Abrams; Deborah Hamolsky; Laura Dunn; Hope Rugo; Marylin Dodd; Steven M Paul; John Neuhaus; Bruce Cooper; Brian Schmidt; Dale Langford; Janine Cataldo; Bradley E Aouizerat
Journal:  J Pain       Date:  2012-04-18       Impact factor: 5.820

8.  Analgesia and central side-effects: two separate dimensions of morphine response.

Authors:  Joanne M Droney; Sophy K Gretton; Hiroe Sato; Joy R Ross; Ruth Branford; Kenneth I Welsh; William Cookson; Julia Riley
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

9.  A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic.

Authors:  Sunil X Raj; Morten Thronaes; Cinzia Brunelli; Marianne J Hjermstad; Pål Klepstad; Stein Kaasa
Journal:  Support Care Cancer       Date:  2014-03-05       Impact factor: 3.603

Review 10.  Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.

Authors:  Pamela L Wolters; Staci Martin; Vanessa L Merker; Kathy L Gardner; Cynthia M Hingtgen; James H Tonsgard; Elizabeth K Schorry; Andrea Baldwin
Journal:  Neurology       Date:  2013-11-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.